Fraud Investigation Opened: Levi & Korsinsky Investigates Above Food Ingredients Inc. (ABVE) on Behalf of Shareholders

NEW YORK, NY / ACCESS Newswire / December 19, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation into Above Food Ingredients Inc. ("Above Food Ingredients Inc.") (NASDAQ:ABVE) concerning potential violations of the federal securities laws.

Above Food revealed on December 12, 2025, that "the timetable" of its fiscal year 2025 audit "has been impacted over the past several weeks by unavoidable illness-related resourcing challenges faced by the team" and would not be completed on time. The Company stated that it "has notified Nasdaq accordingly and has applied for the 180-day extension."

Following this news, Above Food’s stock price fell over 43% on December 15, 2025.

If you suffered a loss on your Above Food Ingredients Inc. securities and would like to explore a potential recovery under the federal securities laws, Learn More About the Investigation or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates.

WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212)363-7500
Fax: (212)363-7171

SOURCE: Levi & Korsinsky, LLP

View the original press release on ACCESS Newswire

comtex tracking

COMTEX_471245133/2457/2025-12-19T13:45:11

Scroll to Top